Drugs / c610
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06082570 | Oct 2023 → Mar 2025 | cancer | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | c610 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06082570 ↗ |
| Route | Intravenous | “one-time intravenous infusion” NCT06082570 ↗ |